Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Inventory (2020 - 2025)

Celularity has reported Change in Inventory over the past 6 years, most recently at -$2.3 million for Q3 2025.

  • Quarterly results put Change in Inventory at -$2.3 million for Q3 2025, down 358.65% from a year ago — trailing twelve months through Sep 2025 was -$9.2 million (down 43.16% YoY), and the annual figure for FY2024 was -$6.3 million, down 826.47%.
  • Change in Inventory for Q3 2025 was -$2.3 million at Celularity, up from -$3.7 million in the prior quarter.
  • Over the last five years, Change in Inventory for CELU hit a ceiling of $9.0 million in Q2 2022 and a floor of -$3.7 million in Q2 2025.
  • Median Change in Inventory over the past 5 years was $61000.0 (2022), compared with a mean of $493315.8.
  • Biggest five-year swings in Change in Inventory: skyrocketed 2692.16% in 2021 and later crashed 1313.11% in 2023.
  • Celularity's Change in Inventory stood at $2.6 million in 2021, then crashed by 97.69% to $61000.0 in 2022, then crashed by 1313.11% to -$740000.0 in 2023, then grew by 14.73% to -$631000.0 in 2024, then crashed by 265.61% to -$2.3 million in 2025.
  • The last three reported values for Change in Inventory were -$2.3 million (Q3 2025), -$3.7 million (Q2 2025), and -$2.6 million (Q1 2025) per Business Quant data.